Maternal Lead Exposure Induces Down-regulation of Hippocampal Insulin-degrading Enzyme and Nerve Growth Factor Expression in Mouse Pups.
- Author:
Xing LI
1
;
Ning LI
2
;
Hua Lei SUN
1
;
Jun YIN
1
;
Yu Chang TAO
1
;
Zhen Xing MAO
1
;
Zeng Li YU
1
;
Wen Jie LI
1
;
John D BOGDEN
3
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Down-Regulation; Female; Gene Expression Regulation, Developmental; drug effects; Gene Expression Regulation, Enzymologic; drug effects; Hippocampus; drug effects; growth & development; metabolism; Insulysin; genetics; metabolism; Lead; toxicity; Mice; Pregnancy; Prenatal Exposure Delayed Effects; chemically induced
- From: Biomedical and Environmental Sciences 2017;30(3):215-219
- CountryChina
- Language:English
- Abstract: Lead exposure is a known potential risk factor for neurodegenerative diseases such as Alzheimer's disease (AD). Exposure to lead during the critical phase of brain development has been linked with mental retardation and hypophrenia in later life. This study was aimed to investigate the effects of lead exposure of pregnant mice on the expressions of insulin-degrading enzyme (IDE) and nerve growth factor (NGF) in the hippocampus of their offspring. Blood samples were collected from the tail vein, and after anesthetizing the pups, the brain was excised on postnatal day 21. Lead concentrations were determined by graphite furnace atomic absorption spectrophotometry, and the expressions of IDE and NGF were determined by immunohistochemistry and Western blotting. Results showed that the reduction in IDE and NGF expression in the hippocampus of pups might be associated with impairment of learning and memory and dementia induced by maternal lead exposure during pregnancy and lactation.
